Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentino Conter

Showing results (61-70 of 131) with videos related to

Pageof 14
Sort By:
Haematologica|September 13, 2005
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 studyMaurizio Aricò, Valentino Conter, Maria Grazia Valsecchi, et al.
Cancer Chemotherapy and Pharmacology|April 21, 2017
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulationsAndrea Ballerini, Federico Moro, Ilaria Fuso Nerini, et al.
Lancet (London, England)|August 23, 2005
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective studyAdriana Balduzzi, Maria Grazia Valsecchi, Cornelio Uderzo, et al.
Pediatric Blood & Cancer|March 7, 2022
NUP214-ABL1 fusion in childhood T-ALLGiulia Veltri, Max Sandei, Daniela Silvestri, et al.
Haematologica|April 17, 2008
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting timeAdriana Balduzzi, Paola De Lorenzo, André Schrauder, et al.
British Journal of Haematology|February 24, 2026
Invasive yeast infection in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009Andreas H Groll, Simone Cesaro, Julia Alten, et al.
Pediatric Blood & Cancer|August 3, 2006
Protocol-based treatment for children with cancer in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)--part IIScott C Howard, Roberta Ortiz, Luis Fulgencio Baez, et al.
Haematologica|July 18, 2024
No clear benefit of preventive cranial radiotherapy in childhood Philadelphia-positive acute lymphoblastic leukemia: a retrospective analysis of the EsPhALL2010 studyValentino Conter, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
Cancers|May 28, 2022
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD)Luca Lo Nigro, Nellina Andriano, Barbara Buldini, et al.
Pediatric Blood & Cancer|June 12, 2020
Collateral effects of COVID-19 pandemic in pediatric hematooncology: Fatalities caused by diagnostic delayRosanna Parasole, Pio Stellato, Valentino Conter, et al.
Pageof 14

Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Haematologica|September 13, 2005
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 studyMaurizio Aricò, Valentino Conter, Maria Grazia Valsecchi, et al.
Cancer Chemotherapy and Pharmacology|April 21, 2017
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulationsAndrea Ballerini, Federico Moro, Ilaria Fuso Nerini, et al.
Lancet (London, England)|August 23, 2005
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective studyAdriana Balduzzi, Maria Grazia Valsecchi, Cornelio Uderzo, et al.
Pediatric Blood & Cancer|March 7, 2022
NUP214-ABL1 fusion in childhood T-ALLGiulia Veltri, Max Sandei, Daniela Silvestri, et al.
Haematologica|April 17, 2008
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting timeAdriana Balduzzi, Paola De Lorenzo, André Schrauder, et al.
British Journal of Haematology|February 24, 2026
Invasive yeast infection in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009Andreas H Groll, Simone Cesaro, Julia Alten, et al.
Pediatric Blood & Cancer|August 3, 2006
Protocol-based treatment for children with cancer in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)--part IIScott C Howard, Roberta Ortiz, Luis Fulgencio Baez, et al.
Haematologica|July 18, 2024
No clear benefit of preventive cranial radiotherapy in childhood Philadelphia-positive acute lymphoblastic leukemia: a retrospective analysis of the EsPhALL2010 studyValentino Conter, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
Cancers|May 28, 2022
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD)Luca Lo Nigro, Nellina Andriano, Barbara Buldini, et al.
Pediatric Blood & Cancer|June 12, 2020
Collateral effects of COVID-19 pandemic in pediatric hematooncology: Fatalities caused by diagnostic delayRosanna Parasole, Pio Stellato, Valentino Conter, et al.
Pageof 14